Dr Agyarko- Poku Thomas Dr Yeboah- Awudzi Kwasi

Slides:



Advertisements
Similar presentations
HIV Counselling and Testing
Advertisements

Integrating Family Planning into PMTCT Services: Promising Approaches from Tanzania’s Iringa and Manyara Regions Mwanga F; Paul Perchal; Motta W; Killian.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
EMTCT Tanzania Experience 6 th Joint Biennial HIV & AIDS Sector Review Dr MD Kajoka PMTCT Coordinator.
Partnerships for PMTCT in Uganda A presentation to the IAS conference AVSI Side Event - Washington 25 July 2012 May Anyabolu Deputy Representative UNICEF.
PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,
Improving Retention, Adherence, and Psychosocial Support within PMTCT Services: Implementation Workshop for Health Workers All slide illustrations by Petra.
Dr Tin Tin Sint Department of HIV/AIDS World Health Organization
Effectiveness of the National PMTCT Program in Rwanda
Designing a National PMTCT Impact Evaluation for Option B+ in Malawi Dr. Beth A. Tippett Barr, CDC-Malawi AIDS Turning the Tide Together.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Washington D.C., USA, July 2012www.aids2012.org Economic Evaluation of the National Program to Prevent Mother-to-Child Transmission of HIV in Ghana.
Prevention of Mother-to-Child Transmission of HIV in Ghana
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Maternal and Newborn Health Training Package Session 11:
THE CORE STUDY COMPARING TWO STRATEGIES FOR ENROLLING HIV-INFECTED PREGNANT WOMEN FROM ANTENATAL CARE TO CARE AND TREATMENT SERVICES IN CAMEROON: CONTINUUM.
Antiretroviral Treatment of Mothers: interrupting vertical transmission Dr Angela Mushavi National PMTCT and Pediatric HIV Care and Treatment Coordinator.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Pediatric HIV Care & Treatment in Uganda A Five-Day Training Course For Health Professionals.
Operational challenge: Linkages from prevention of mother-to-child transmission services to care and treatment services in Zambia S. Okawa,
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Presenter : Dr T. G. Nematadzira on behalf of The IMPAACT PROMISE 1077BF/1077FF Team Efficacy and Safety of Two Strategies to Prevent Perinatal HIV Transmission.
PMTCT at Different Levels of Care: The Uganda Experience Dr. Saul Onyango National PMTCT Coordinator Ministry of Health 1 1.
Zimbabwe National HIV&AIDS Conference, Harare, 5-8 Sept 2011
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV WHAT’S NEW Prepared by Dr. Debbie Carrington National HIV/AIDS Prevention & Control Programme Ministry.
The Rationale for Option B+ in Malawi
ANC-HIV INTEGRATION Countdown to zero; is it time for a gear shift? Dr Elizabeth Anne Bukusi, MBChB, M.Med (ObGyn), MPH, PhD PGD (Research Ethics) Deputy.
Translating the Vision Towards Universal Access Dr Zengani Chirwa.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
PMTCT: a moving target or a moving strategy? 23rd June 2008 MSF Access Campaign.
Integration of Antiretroviral Therapy (ART) in Maternal and Child Health (MCH) settings: the way forward for increasing access to ART for.
Human Resource Constraints and Roll out of more efficacious regimens for PMTCT The Zambian experience Nande Putta MD MPH Technical Assistant PMTCT & Paediatric.
Strengthening HR Capacity to Address the HIV Crisis Dr. Mphu Ramatlapeng Minister of Health, Lesotho 2 February 2012 Father Michael Kelly Lecture.
T Mukotekwa 1, D Patel, B Engelsmann 1 1 Organization for Public Health Interventions and Development Trust (OPHID), Harare, Zimbabwe Zimbabwe National.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Integrating ART/PMTCT services into MNCH services to enhance test & treat strategy for HIV infected pregnant and lactating women (Option B+) WHO Satellite.
WHO PMTCT ARV Guidelines 2012 Programmatic Update EFV During Pregnancy Nathan Shaffer PMTCT Technical Lead, WHO IATT Webinar 11 July, 2012.
Charles S. Kiptemas, MBChB, MPH Director South Rift Valley HIV Care & Treatment Program Kenya Medical Research Institute/Walter Reed Project Track 1 Partners.
Module 2: Learning Objectives
Impact of Early Infant Diagnostic (EID) Testing for HIV Exposed Infants in Namibia Dr. Ndapewa Hamunime (MOHSS) Dr. Andreas Shiningavamwe (NIP) Republic.
Prevention of Mother to Child Transmission Antiretroviral Drugs to Prevent MTCT.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Late maternal HIV testing, HCMC Chi K. Nguyen 1, Haily T. Pham 2, ThuVan T. Tieu 2, Chinh.
PMTCT - The Platform for integrating HIV/AIDS Services in the MCH Clinic. Bola Oyeledun, MD, MPH Track 1.0 Partners Meeting Washington DC. August 2008.
MATERNAL ANTIRETROVIRAL THERAPY AND INFANT OUTCOMES THROUGHOUT THE FIRST YEAR OF LIFE: results from the DREAM study in Dschang, Cameroon Taafo F, Doro.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
Assessment of in-service HIV training in Swaziland 7 th Dec, 2011 Zwane-Shabalala FS 1, Nxumalo-Magagula N 1, Mngadi P.T 1, Kamiru H.N 3, Bruce K 3, Schulman.
11 Laboratory Quality Improvement for clinical HIV/AIDS Services in the Uniformed Forces Mwaibako, J, Shija, L; Haverkamp, G; van den Hombergh; Katebalila,
Accelerated transition to Option B+ in a rural Zimbabwean province: Impact of a Decentralised ART System. Tendai E. Nyagura* 1, C. Tshuma 1, S. Mukungunugwa.
1 Strengthening PMTCT Data Reporting and Use through Supportive Supervision and Routine Performance Evaluation: Experiences from Dedza and Ntcheu Districts,
Diagram: Four stages of PMTCT Primary prevention of HIV Antenatal Care Labour and delivery Postnatal Care.
Decentralization of Option B+ services and implications for task shifting Dr Franck Fwamba N’kulu National AIDS & STI Control Programme Democratic Republic.
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
How did we miss them? High HIV prevalence among Women testing for the First Time in Labour and Delivery in Zimbabwe Page-Mtongwiza S, Webb, K., Chiguvare,
Equity focused bottleneck analysis and development of costed evidence informed national plan for MTCT elimination: United Republic of Tanzania Dr. Deborah.
Human rights and ethical dilemmas in the implementation of Option B+ in Malawi Alister C. Munthali, Blessings Chinsinga and John Kadzandira Centre for.
1 Addressing nutrition of mothers and babies in partnership for HIV – Free Survival (PHFS) sites to improve their well-being DR. STELLA KASINDI MWITA SENIOR.
ADVANCING HIV NURSING PRACTICE IN THE COMMUNITY
PrEP Scale Up in Kenya: Bridge to Scale Project
How differentiated care supports “Tx all” and Dr
Justine Mirembe MD, MPH ICASA, 5th December 2011
“Treatment for all pregnant women:
PMTCT Prongs 1 & 2 and the repositioning of Family Planning ICASA 2011
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
Training & Program Delivery Gear Meeting 2 presentation
Community–led qualitative research
What Will It Take To End Pediatric AIDS
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Perceived barriers and facilitators to adherence to antiretroviral therapy among persons living with HIV in the Upper East Region Dr. Gifty Apiung Aninanya,
Assessment of the utilization of prevention of mother-to-child transmission of HIV services and health outcomes of infants born to HIV positive mothers.
Multi-disease diagnostic integration
Dismas Gashobotse, MD FHI 360/LINKAGES, Burundi
Presentation transcript:

Dr Agyarko- Poku Thomas Dr Yeboah- Awudzi Kwasi PMTCT OPTION B+ IMPLEMENTATION AT THE PRIMARY LEVEL OF CARE IN THE ASHANTI REGION OF GHANA; CHALLENGES. Bandoh Dennis Dr Agyarko- Poku Thomas Dr Yeboah- Awudzi Kwasi

OUTLINE BACKGROUND OBJECTIVES METHOD RESULTS/KEY FINDINGS RECOMMENDATIONS CONCLUSION ACKNOLEDGEMENT

BACKGROUND The more efficacious Option B+ strategy for the prevention of mother- to-child transmission (PMTCT) of HIV has been implemented in Ghana over the past four years including the provision of ART services at the primary level of care. OBJECTIVE : This baseline study assesses challenges facing service delivery of Option B+ at the primary care levels in the Ashanti Region of Ghana. Primary level of care is defined by Ministry of Health, Ghana as CHPS compounds, clinics, maternity homes and health centres.(MOH)

Evolution of PMTCT ARV Recommendations(WHO,NACP) 2001 2004 2006 2010 Launch 2013 PMTCT 4 weeks AZT; AZT+ 3TC, or SD NVP AZT from 28 wks + SD NVP AZT from 28wks + sdNVP +AZT/3TC 7days Option A (AZT +infant NVP) Option B (triple ARVs) Option B or B+ Moving to ART for all PW/BF Move towards: more effective ARV drugs, extending coverage throughout MTCT risk period, and ART for the mother’s health

BACKGROUND (3) -About PMTCT Option B+(WHO) Option B+ is lifelong ART for HIV positive pregnant and lactating women irrespective of clinical stage or CD4 count Benefits of B+ No need for CD4 count before starting B+ No interruption of triple ART ‘’avoid a start-stop-start-stop approach’’ One regimen for all-non-pregnant populations and pregnant women Easier to harmonize with the treatment program Covers future pregnancies esp with high fertility Provided at the primary levels of health care

BACKGROUND - PMTCT KEY INDICATORS (ASH HIV ANNUAL REPORT,2017) PMTCT SITES 453 PMTCT SITES OFFERING ARV’S(OPTION B+) 297 PMTCT COVERAGE 87.7%(141,280) NUMBER ,%POSITIVE PMTCT 1.6%(2279) PMTCT ART COVERAGE 90.6% OPTION B +

METHOD Four hundred and fifty health(450) care providers made up of health care assistants, community nurses, enrolled nurses, midwives, physician assistants were selected from 75 health facilities. Facility geographical location (Urban and Rural) and ownership (Public, Private and Mission) were conferred. Sampling Methods – Purposive Sampling (PMTCT Sites Implementing Option B+) and Simple Random Sampling(75 Facilities) Data including socio-demographic information was collected using structured questionnaire. Data was analysed using SPSS 16.

RESULTS

Geographical Location/Facility Ownership/Facility Type NUMBER CHPS 24 CLINIC 3 MATERNITY HOMES 8 HEALTH CENTRES 40

SOCIO DEMOGRAPHIC INFORMATION(1)- CADRE

RESULTS Majority (68.1%; 307/450) of respondents were aged 45 years and below. More than half (56.9%; 256/450) of the respondents had worked just under 2 years, with 32.1%; (144/450) and 11.0% (49/450) over 2 years and 4 years respectively. 90.1%(405/450) mentioned stigmatization as explained by closeness of the health facility to their communities, preventing the women to access care. 65.1%(293/450) reported uncooperative attitude of pharmacist in terms of releasing of ARVs. Lack of confidence to administer ARV’s among the respondents was a major issue from inadequate training (70.2%; 316/450). Erratic supplies of logistics including medicines and Ora-Quick to confirm reactive cases were a major concern for over three-quarters of the respondents (72.9%; 328/450). 43.1% (194/450) Reported that Mothers are discouraged because Positive male partners are not allowed to take ARV’s from the PMTCT Sites but rather referred to ART sites Lack of Lab investigation at the lower levels due to unavailability of labs, trained personnel or equipment were reported by some respondents as a hindrance to initiating clients on ARV(25.2%:113/450 ) Continuum of Care after Delivery ? There were no significant differences for the respondents’ responses and geographical location (p-value 0.789) and facility ownership (p-value -0.699).

SUMMARY OF KEY FINDINGS

RECOMENDATIONS Training at lower level staff to build the trust of pharmacists to hand over ARVs to lower levels and also boost their confidence in administering ARV’s Regular Supervision, optimized mentoring from higher levels to provide on the spot trainings and corrective measures to improve capacity of HCW. Eg .Pharm should be supported to undertake supervision of ARV’s. Improved logistic management including quantification and forecasting to ensure uninterrupted supply of drugs and commodities Barriers caused by closeness of facility can be addressed through continuous Community sensitization and opinion leaders engagements to build trust of clients to attend the nearest facilities Capacity building of lab staff ,Logistical and infrastructure support to enable laboratory testing at the primary levels. Strategize to address the issue of ARV’s not given to male partners at PMTCT sites (Eg. Scaling up of PMTCT sites to provide ART, Task Sharing)

CONCLUSION The study found the fear of stigmatization due to closeness of facility as the main challenge for the implementation of Option B+ at the primary level of care ,other factors like erratic supply of commodities, inadequate training and lack of support from pharmacist are the main challenges facing health care providers at the primary levels of care. There is the need to urgently attend to these challenges to ensure the success of the PMTCT option B+.

ACKNOLEDGEMENT RDHS ,RHD Health Facilities DHA’s Pharm Kwaku Koduah

MEDAASE